Review article · 2024 · Open access

Artificial Intelligence (AI) Applications in Drug Discovery and Drug Delivery: Revolutionizing Personalized Medicine

Dolores R. Serrano, Francis C. Luciano, Brayan J. Anaya, Baris Öngoren, Aytug Kara, Gracia Molina, Bianca I. Ramirez, Sergio A. Sánchez-Guirales, Jesus A. Simon, Greta Tomietto, Chrysi Rapti, Helga K. Ruiz and 3 more

Pharmaceutics, 16(10), 1328 · Published 14 October 2024 · DOI 10.3390/pharmaceutics16101328

Free PDFView at the publisherCite this paper

In brief

“Artificial Intelligence (AI) Applications in Drug Discovery and Drug Delivery: Revolutionizing Personalized Medicine” is a 2024 review article by Dolores R. Serrano and 14 co-authors, published in Pharmaceutics. OpenAlex counts 598 citations as of 15 November 2026, which puts it in the top 2% of works published in 2024 by citations. It is open access under a CC BY licence: the full text is free to read at Pharmaceutics.

Citations
598
Most cited in
2026 (340)
Field-weighted impact
15.47
References
163
Authors
15

Abstract

Artificial intelligence (AI) encompasses a broad spectrum of techniques that have been utilized by pharmaceutical companies for decades, including machine learning, deep learning, and other advanced computational methods. These innovations have unlocked unprecedented opportunities for the acceleration of drug discovery and delivery, the optimization of treatment regimens, and the improvement of patient outcomes. AI is swiftly transforming the pharmaceutical industry, revolutionizing everything from drug development and discovery to personalized medicine, including target identification and validation, selection of excipients, prediction of the synthetic route, supply chain optimization, monitoring during continuous manufacturing processes, or predictive maintenance, among others. While the integration of AI promises to enhance efficiency, reduce costs, and improve both medicines and patient health, it also raises important questions from a regulatory point of view. In this review article, we will present a comprehensive overview of AI's applications in the pharmaceutical industry, covering areas such as drug discovery, target optimization, personalized medicine, drug safety, and more. By analyzing current research trends and case studies, we aim to shed light on AI's transformative impact on the pharmaceutical industry and its broader implications for healthcare.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Serrano, D. R., Luciano, F. C., Anaya, B. J., Öngoren, B., Kara, A., Molina, G., Ramirez, B. I., Sánchez-Guirales, S. A., Simon, J. A., Tomietto, G., Rapti, C., Ruiz, H. K., Rawat, S., Kumar, D. K., & Lalatsa, A. (2024). Artificial Intelligence (AI) Applications in Drug Discovery and Drug Delivery: Revolutionizing Personalized Medicine. Pharmaceutics, 16(10), 1328. https://doi.org/10.3390/pharmaceutics16101328

MLA 9

Serrano, Dolores R., et al. “Artificial Intelligence (AI) Applications in Drug Discovery and Drug Delivery: Revolutionizing Personalized Medicine.” Pharmaceutics, vol. 16, no. 10, 2024, p. 1328. https://doi.org/10.3390/pharmaceutics16101328.

Chicago

Serrano, Dolores R., Francis C. Luciano, Brayan J. Anaya, Baris Öngoren, Aytug Kara, Gracia Molina, Bianca I. Ramirez, et al. 2024. “Artificial Intelligence (AI) Applications in Drug Discovery and Drug Delivery: Revolutionizing Personalized Medicine.” Pharmaceutics 16 (10): 1328. https://doi.org/10.3390/pharmaceutics16101328.

Harvard

Serrano, D. R. et al. (2024) ‘Artificial Intelligence (AI) Applications in Drug Discovery and Drug Delivery: Revolutionizing Personalized Medicine’, Pharmaceutics, 16(10), p. 1328. doi:10.3390/pharmaceutics16101328.

IEEE

D. R. Serrano et al., “Artificial Intelligence (AI) Applications in Drug Discovery and Drug Delivery: Revolutionizing Personalized Medicine,” Pharmaceutics, vol. 16, no. 10, p. 1328, 2024, doi: 10.3390/pharmaceutics16101328.

BibTeX

@article{serrano2024artificial,
  title     = {{Artificial Intelligence (AI) Applications in Drug Discovery and Drug Delivery: Revolutionizing Personalized Medicine}},
  author    = {Serrano, Dolores R. and Luciano, Francis C. and Anaya, Brayan J. and Öngoren, Baris and Kara, Aytug and Molina, Gracia and Ramirez, Bianca I. and Sánchez-Guirales, Sergio A. and Simon, Jesus A. and Tomietto, Greta and Rapti, Chrysi and Ruiz, Helga K. and Rawat, Satyavati and Kumar, Dinesh K. and Lalatsa, Aikaterini},
  journal   = {Pharmaceutics},
  year      = {2024},
  volume    = {16},
  number    = {10},
  pages     = {1328},
  doi       = {10.3390/pharmaceutics16101328},
  url       = {https://doi.org/10.3390/pharmaceutics16101328}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202488
2025250250
2026340340

Its field-weighted citation impact is 15.47: it has been cited 15.47 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods

  • artificial intelligence in drug discovery
  • drug delivery
  • personalized medicine
  • pharmaceutical industry
  • target identification and validation
  • excipient selection
  • continuous production
  • predictive maintenance

Work with this paper

Most-cited papers in Pharmacology, Toxicology and Pharmaceutics

All highly cited Pharmacology, Toxicology and Pharmaceutics papers

Questions about this paper

How do I cite this paper in APA style?

Serrano, D. R., Luciano, F. C., Anaya, B. J., Öngoren, B., Kara, A., Molina, G., Ramirez, B. I., Sánchez-Guirales, S. A., Simon, J. A., Tomietto, G., Rapti, C., Ruiz, H. K., Rawat, S., Kumar, D. K., & Lalatsa, A. (2024). Artificial Intelligence (AI) Applications in Drug Discovery and Drug Delivery: Revolutionizing Personalized Medicine. Pharmaceutics, 16(10), 1328. https://doi.org/10.3390/pharmaceutics16101328

How many times has this paper been cited?

598 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access: read the free full text at Pharmaceutics.

Who wrote this paper?

Dolores R. Serrano, Francis C. Luciano, Brayan J. Anaya, Baris Öngoren, Aytug Kara, Gracia Molina, Bianca I. Ramirez, Sergio A. Sánchez-Guirales, Jesus A. Simon, Greta Tomietto, Chrysi Rapti, Helga K. Ruiz and 3 more.

What is the DOI of this paper?

10.3390/pharmaceutics16101328. The permanent link is https://doi.org/10.3390/pharmaceutics16101328.

Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.